🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, placebo-controlled phase 2 study was seeking to evaluate t...
Status
Terminated
Location
Viable Research Management_Site number 131
Start Date
2019-06-26
Trial ID
NCT03919799
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and pha...
Status
Completed
Location
Investigational site
Start Date
2014-03-28
Trial ID
NCT05918614
Treatments Being Tested
This phase II trial compares the effect of belumosudil to a placebo in trea...
Status
Recruiting
Location
City of Hope
Start Date
2023-12-06
Trial ID
NCT05996627
Treatments Being Tested
This is a phase 2, randomized, placebo-controlled, 2-period study to evalua...
Status
Completed
Location
Alliance Dermatology and Mohs Center
Start Date
2016-09-14
Trial ID
NCT02852967
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and pha...
Status
Completed
Location
Investigational site
Start Date
2013-11-21
Trial ID
NCT05918588
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled trial in de novo kid...
Status
Enrolling By Invitation
Location
Houston Methodist Research Institute
Start Date
2025-09-11
Trial ID
NCT06751602
Treatments Being Tested
This double-blind, randomized, placebo-controlled, multinational, multicent...
Status
Recruiting
Location
University of Alabama at Birmingham- Site Number : 8400026
Start Date
2023-10-10
Trial ID
NCT06082037
Treatments Being Tested
The purpose of this study is to see if taking the study drug, Belumosudil, ...
Status
Recruiting
Location
University of California, Los Angeles (Site #: 71123)
Start Date
2025-03-12
Trial ID
NCT06476132
Treatments Being Tested